Navigation Links
Biocept and Clarient Announce Collaboration on First Test for Circulating Tumor Cells and HER2 Status in Breast Cancer Patients
Date:8/24/2011

SAN DIEGO, Aug. 24, 2011 /PRNewswire/ -- Biocept, Inc., a privately-held CLIA-certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs) in cancer patients, and Clarient, Inc. (a GE Healthcare Company) today announced a collaboration on the commercialization of a proprietary blood test for CTCs in breast cancer patients, which includes the determination of HER2 status.  Clarient and Biocept will market and sell Biocept's new OncoCEE-BR™ CTC test to community hospitals, pathologists and medical oncologists.  Biocept will perform the test in its laboratories, and results will be interpreted by Clarient's highly respected pathology group (Clarient Pathology Services, Inc.).   The test includes CTC enumeration and HER2 status of the detected CTCs by fluorescence in situ hybridization (FISH); it is the first commercially available CTC test to include analysis of a specific treatment-associated biomarker.  

David Hale, Executive Chairman of Biocept, said, "We are very excited about this collaboration with Clarient, and feel there is real synergy between our two companies.  We believe the combination of the technical advantages of the OncoCEE-BR™ test, and Clarient's highly regarded marketing and pathology capabilities, will enable the rapid education of the physician community about the benefits of CTC analysis for patients with breast cancer."  He continued, "We think a blood-based, CTC-directed HER2 test, which can be performed when a treatment decision arises, has high potential, and expect that it will be used to support other laboratory and clinical information to provide physicians with the most current information on a tumor to help select the most appropriate course of therapy."

The OncoCEE-BR™ test includes enumeration of CTCs as well as the determination of HER2 status by FISH.  Biocept intends to add ER/PR status determination to the test, an
'/>"/>

SOURCE Biocept, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Biocept, Inc. Announces CEO and Director Appointments
2. Biocept, Inc. Announces Two New Director Appointments
3. Biocept, Inc. Announces New Director Appointment - September 28, 2010
4. Biocept Demonstrates Multiple Phenotypes of Circulating Tumor Cells (CTCs) in Cancer Patients
5. Biocept, Inc. Announces New CFO
6. Biocept, Inc. Announces Availability of Its New Breast Cancer Test, OncoCEE-BRâ„¢ Utilizing Circulating Tumor Cells (CTCs)
7. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
8. Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008
9. Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
10. Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners
11. Clarient to Present at Noble Financials 5th Annual Equity Conference on Tuesday, June 9th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
(Date:12/19/2014)... 2014 Naurex Inc., a biopharmaceutical company leveraging ... of the central nervous system, today announced that ... will present at the 33 rd annual J.P. ... at 3:00 p.m. PST on Tuesday, January 13, 2015, ... Francisco, Calif. About Naurex ...
(Date:12/19/2014)... Calif. , Dec. 19, 2014 Bina Technologies, ... USA) announced today that they have been acquired by ... is a privately held company that provides a ... next generation sequencing (NGS) data for the academic and ... Roche Sequencing Unit, and will continue to focus on ...
Breaking Biology Technology:Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... QGLY ) today issued an update on a ... by its wholly owned,subsidiary, Quigley Pharma, http://www.QuigleyPharma.com . ... 100 subjects have been,enrolled, 52 subjects have completed treatment ... IIB study designed to evaluate the safety and,efficacy of ...
... in Atrial Fibrillation, EP Mapping and ... Ablation, PCI and Additional Complex Procedures, ... STXS ) announced today that more than 10,000 ... Stereotaxis system utilizes,advanced, magnet-guided navigational technology intended to ...
... Formally Launches the Sustainable Biodiesel Alliance On September ... of Rock Tour to New York City. Legendary artist ... in Times Square. Dedicated to,its "save the planet" motto, ... official launch of the Sustainable Biodiesel Alliance. Award-winning,actors Woody ...
Cached Biology Technology:Quigley Corporation Releases Update on Quigley Pharma's Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy 2Quigley Corporation Releases Update on Quigley Pharma's Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy 3Stereotaxis' Niobe System Used to Perform More Than 10,000 Procedures Worldwide 2Stereotaxis' Niobe System Used to Perform More Than 10,000 Procedures Worldwide 3MultiVu Video Feed: Hard Rock's 2007 Ambassadors of Rock Tour Is "On the Road Again" With Music Legend Willie Nelson 2
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ... to expand its team and bring LaunchKey to market ...
(Date:12/17/2014)... DUBLIN , Dec. 16, 2014 Research ... announced the addition of the "Global Chemical ... http://photos.prnewswire.com/prnh/20130307/600769 ... is the increasing demand for medical sensors in ... patient data for quick and correct diagnosis during ...
(Date:12/11/2014)... Dec. 10, 2014  That blood pressure plays a role ... Hypertension – the medical term for high blood pressure – ... and the inflatable cuff that,s used in measuring blood pressure ... there,s nothing new about hypertension, its triggers and its effects. ... the condition and the best ways to treat it. ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... FAIRFAX, Va.For the first time, the Society of ... professional articles about uterine artery embolization, a treatment directed ... adverse health effects that may occur due to the ... and Interventional Radiology "virtual" collection allows health care ...
... Conservation Society announced today that critically endangered alligators in ... WCS,s Bronx Zoo, in partnership with two other North ... Management of the State Forestry Administration of China, has ... multiplying on their own. The alligator hatchlings15 in ...
... is the foundation of the body,s immune response and ... is part of the immune system, and recognizes certain ... HIV. How the molecule binds to pathogens has been ... by University of Illinois chemist Deborah Leckband show that ...
Cached Biology News:Avoiding hysterectomy: Major interventional radiology E-collection info available 2Avoiding hysterectomy: Major interventional radiology E-collection info available 3Reintroduced Chinese alligators now multiplying in the wild in China 2Reintroduced Chinese alligators now multiplying in the wild in China 3Flexible neck in cell-receptor DC-SIGN targets more pathogens 2
... is a two color staining method for ... to detect apoptotic cells by flow cytometry. ... required for measuring apoptosis in cells including: ... reagent performance; washing, reaction and rinsing buffers ...
... GT and PowerPac 3000 system, 220-240 V, is ... x 50 cm vertical slab gel format. The ... which is capable of separating nucleic acids with ... chamber (IPC) assembly (IPC and bonded inner glass ...
... PROTEAN Plus overlay agarose is ... to secure IPG strips in place ... tracking dye is incorporated to allow ... is composed of 0.75% agarose in ...
... PowerPac HV high-voltage power supply, with temperature probe, ... of 5,000 V, 500 mA, and 400 W. ... temperature between 0 and 90 degrees C during ... transfer. Power cord and instructions are provided. Dimensions ...
Biology Products: